Skip to main content
Log in

Follow-up evaluation of patients with Graves’ disease treated by subtotal thyroidectomy and risk factor analysis for postoperative thyroid dysfunction

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Eight-year follow-up evaluation and analysis of factors related to postoperative thyroid dysfunction were made in 216 patients with Graves’ disease treated by subtotal thyroidectomy. The postoperative status of thyroid function were as follows according to hypersensitive TSH level: 65 patients (30.1%) were euthyroid, 25 (11.5%) had overt hyperthyroidism requiring treatment, 14 (6.5%) had subclinical hyperthyroidism with normal thyroid hormone and suppressed TSH, 21 (9.8%) were overt hypothyroid requiring thyroid hormone replacement and 91 (41.1%) had latent hypothyroidism without hormone replacement. In order to know factors related to postoperative thyroid function, age, sex, preoperative levels of TSH receptor antibody (TRAb), thyroid antibody titers, degree of lymphocyte infiltration, duration of medical treatment, weight of the resected thyroid tissue and weight of the remnant thyroid tissue were determined. No factor except thyroid remnant and antimicrosomal antibody titer was related to postoperative thyroid function. The weight of remnant should be less than 6 g to avoid recurrent hyperthyroidism. As recurrence of hyperthyroidism was observed more than 5 yr after surgery, long follow-up is needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Michie W., Beck J.S., Pollet J.E. Prevention and management of hypothyroidism after thyroidectomy for thyrotoxicosis. World J. Surg. 2:306, 1978.

    Article  Google Scholar 

  2. Toft A.D., Irvine W.J., Sinclair L., Mcintosh D., Seth J., Cameron E.H.D. Thyroid function after surgical treatment of thyrotoxicosis. A report of 100 cases treated with propranolol before operation. N. Engl. J. Med. 298:643, 1978.

    Article  CAS  PubMed  Google Scholar 

  3. Hedley A.J., Bewsher P.D., Jones S.J., Khir A.S.M., Clements P., Matheson N.A., Gunn A. Late onset hypothyroidism after subtotal thyroidectomy for hyperthyroidism: implications for long term follow-up. Br. J. Surg. 70:740, 1983.

    Article  CAS  PubMed  Google Scholar 

  4. Makiuchi M., Miyakawa M., Sugenoya A., Furihata R. An evaluation of several prognostic factors in the surgical treatment for thyrotoxicosis. Surg. Gynecol. Obstet. 152:639, 1981.

    CAS  PubMed  Google Scholar 

  5. Kasuga Y., Sugenoya A., Kobayashi S., Kaneko G., Masuda H., Fujimoto M., Iida F. Clinical evaluation of the response to surgical treatment of Graves’ disease. Surg. Gynecol. Obstet. 170:327, 1990.

    CAS  PubMed  Google Scholar 

  6. Cusick E.L., Krukowski A.H., Matheson N.A. Outcome of surgery for Graves’ disease re-examined. Br. J.Surg. 74:780, 1987.

    Article  CAS  PubMed  Google Scholar 

  7. Jortso E., Lennquist S., Lundstrom B., Norrby K., Smeds S. The influence of remnant size, antithyroid antibodies, thyroid morphology, and lymphocyte infiltration on thyroid function after subtotal resection for hyperthyroidism. World J. Surg. 11:365, 1987.

    Article  CAS  PubMed  Google Scholar 

  8. Bradley E.L., Liechty R.D. Modified subtotal thyroidectomy for Graves’ disease: A two-institution study. Surgery 94:955, 1983.

    PubMed  Google Scholar 

  9. Steel N.R., Taylor J.J., Young E.T., Farndon J.R., Holcombe M., Kendall-Taylor P. The effect of subtotal thyroidectomy with propranolol preparation on antibody activity in Graves’ disease. Clin. Endocrinol. (Oxf.) 26:97, 1987.

    Article  CAS  Google Scholar 

  10. Hamada N., Ito K., Mimura T., Ishikawa N., Momotani N., Noh J., Hosoda Y., Morii H. Retrospective revaluation of the significance of thyroid microsomal antibody in the treatment of Graves’ disease. Acta Endocrinol. (Copenh.) 114:328, 1987.

    CAS  Google Scholar 

  11. van Welsum M., Feltkamp T.E.W., de Vries M.J., Docter R., van Zijl J., Hennemann G. Hypothyroidism after thyroidectomy for Graves’ disease: A search for an explanation. Br. Med. J. 4:755, 1974.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Whitesell F.B. Jr., Black B.M. A statistical study of the clinical significance of lymphocytic and fibrocytic replacements in the hyperplastic thyroid gland. J. Clin. Endocrinol. Metab. 9:1202, 1949.

    Article  PubMed  Google Scholar 

  13. Busnardo B., Cirelli M.E., Rubello D., Eccher C., Betterle C. Long term thyroid function after thyroidectomy for Graves’ disease. J. Endocrinol. Invest. 77:371, 1988.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sugino, K., Mimura, T., Toshima, K. et al. Follow-up evaluation of patients with Graves’ disease treated by subtotal thyroidectomy and risk factor analysis for postoperative thyroid dysfunction. J Endocrinol Invest 16, 195–199 (1993). https://doi.org/10.1007/BF03344945

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03344945

Key-words

Navigation